Additionally, the immunoinhibitor LAG3 was significantly highly expressed in the ERS high-risk subgroup (p < 0.001), but CD160, CD274, KDR, PDCD1LG2, and TGFBR1 were expressed significantly less (Fig. 9D). Here, TGFBR1 is linked to amelogenesis imperfecta type 1G.